StemCells Inc (NASDAQ:STEM) Comes Out With Pricing of PO To Raise $25 Million

In order to raise additional capital, StemCells Inc (NASDAQ:STEM) has decided to price an underwritten public offering. As per the reports, the pricing of the underwritten public offering of warrants and common stock shares will help it raise $25 million, which will be used for corporate activities. Road Ahead: The company has decided to offer […]

StemCells Inc (NASDAQ:STEM) High On Positive Trial Data

Boston, MA 06/19/2014 (wallstreetpr) – StemCells Inc (NASDAQ:STEM) is high on something today. The company reported widely positive results from the Phase 1/2 study of its age-related muscular degeneration (AMD) treatment. The results showed that HuCNS-SC led to significant vision improvement on patients tried. The drug is poised to enter the next level of trial […]